Sandra M Leon-Garcia1, Hilary A Roeder1, Katharine K Nelson2, Xiaoyan Liao2, Donald P Pizzo2, Louise C Laurent1, Mana M Parast2, D Yvette LaCoursiere3. 1. Department of Reproductive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. 2. Department of Pathology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. 3. Department of Reproductive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. Electronic address: dlacoursiere@ucsd.edu.
Abstract
OBJECTIVE: Adverse effects of obesity have been linked to inflammation in various tissues, but studies on placental inflammation and obesity have demonstrated conflicting findings. We sought to investigate the influence of pregravid obesity and fetal sex on placental histopathology while controlling for diabetes and hypertension. METHODS: Placental histopathology focusing on inflammatory markers of a cohort of normal weight (BMI = 20-24.9) and obese (BMI ≥ 30) patients was characterized. Demographic, obstetric and neonatal variables were assessed. RESULTS: 192 normal and 231 obese women were included. Placental characteristics associated with obesity and fetal sex independent of diabetes and hypertension were placental disc weight >90(th) percentile, decreased placental efficiency, chronic villitis (CV), fetal thrombosis, and normoblastemia. Additionally, female fetuses of obese mothers had higher rates of CV and fetal thrombosis. Increasing BMI increased the risk of normoblastemia and CV. The final grade and extent of CV was significantly associated with obesity and BMI, but not fetal gender. Finally, CV was less common in large-for-gestation placentas. CONCLUSIONS: Maternal obesity results in placental overgrowth and fetal hypoxia as manifested by normoblastemia; it is also associated with an increased incidence of CV and fetal thrombosis, both more prevalent in female placentas. We have shown for the first time that the effect of maternal obesity on placental inflammation is independent of diabetes and hypertension, but significantly affected by fetal sex. Our data also point to the intriguing possibility that CV serves to normalize placental size, and potentially fetal growth, in the setting of maternal obesity.
OBJECTIVE: Adverse effects of obesity have been linked to inflammation in various tissues, but studies on placental inflammation and obesity have demonstrated conflicting findings. We sought to investigate the influence of pregravid obesity and fetal sex on placental histopathology while controlling for diabetes and hypertension. METHODS: Placental histopathology focusing on inflammatory markers of a cohort of normal weight (BMI = 20-24.9) and obese (BMI ≥ 30) patients was characterized. Demographic, obstetric and neonatal variables were assessed. RESULTS: 192 normal and 231 obesewomen were included. Placental characteristics associated with obesity and fetal sex independent of diabetes and hypertension were placental disc weight >90(th) percentile, decreased placental efficiency, chronic villitis (CV), fetal thrombosis, and normoblastemia. Additionally, female fetuses of obese mothers had higher rates of CV and fetal thrombosis. Increasing BMI increased the risk of normoblastemia and CV. The final grade and extent of CV was significantly associated with obesity and BMI, but not fetal gender. Finally, CV was less common in large-for-gestation placentas. CONCLUSIONS:Maternal obesity results in placental overgrowth and fetal hypoxia as manifested by normoblastemia; it is also associated with an increased incidence of CV and fetal thrombosis, both more prevalent in female placentas. We have shown for the first time that the effect of maternal obesity on placental inflammation is independent of diabetes and hypertension, but significantly affected by fetal sex. Our data also point to the intriguing possibility that CV serves to normalize placental size, and potentially fetal growth, in the setting of maternal obesity.
Authors: Kristin Palmsten; Katharine K Nelson; Louise C Laurent; Soojin Park; Christina D Chambers; Mana M Parast Journal: Placenta Date: 2018-06-06 Impact factor: 3.481
Authors: Amy R Nichols; Andrew G Rundle; Pam Factor-Litvak; Beverly J Insel; Lori Hoepner; Virginia Rauh; Frederica Perera; Elizabeth M Widen Journal: J Dev Orig Health Dis Date: 2019-09-05 Impact factor: 2.401
Authors: Matthew Bucher; Kim Ramil C Montaniel; Leslie Myatt; Susan Weintraub; Hagai Tavori; Alina Maloyan Journal: J Dev Orig Health Dis Date: 2020-11-13 Impact factor: 2.401
Authors: Raymond W Redline; Sanjita Ravishankar; Christina M Bagby; Shahrazad T Saab; Shabnam Zarei Journal: Mod Pathol Date: 2021-02-08 Impact factor: 8.209